Skip to main content

CORRECTION article

Front. Pharmacol.
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1488083

Corrigendum: Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling

Provisionally accepted
Bin Zhang Bin Zhang *Sun Xiaobo Sun Xiaobo *Guibo Sun Guibo Sun *
  • Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

This article is a correction to:

  1. Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling

    1. Read original article

The final, formatted version of the article will be published soon.

    Corrigendum on: Zhang B, Zhang J, Zhang C, Zhang X, Ye J, Kuang S, Sun G and Sun X (2018) Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling. Front. Pharmacol. 9:1227Pharmacol. 9: . doi: 10.3389/fphar.2018.01227 .01227 In the published article, there was an error in Figures 2F, Figure 3A, E and Figures 8C as published. Specifically, Western blot pictures of HO-1and NQO-1 in Figure 2F were misplaced.After checking the raw data, the misplaced Western blot pictures of HO-1and NQO-1 were corrected. The corrected Figures 2 and its caption appears below.In the published article, there was an error in Figures 3A,E. The TUNEL staining picture in AGEs group was misplaced in Figures 3A. Additionally, the Western blot pictures of Bcl-2 and cleaved casp-3 were misplaced in Figure 3E. After checking the raw data, the misplaced bands of Bcl-2 and cleaved casp-3 were corrected. The misplaced Lamin B1 and β-actin bands in Figure 8C were also corrected. The corrected Figures 3 and8 and its caption appears below. and HO-1) showed that NGR1 promoted the translocation of Nrf2 to the nucleus. This was associated with the up-regulation of these anti-oxidant enzymes. The quantitative data are presented as the mean ± SD (n = 3). ## P < 0.01 vs. the Control group, * P < 0.05 or ** P < 0.01 vs. the AGEs group.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: Diabetes Mellitus, Diabetic cardiomyopathy, estrogen receptor, Apoptosis, Oxidative Stress

    Received: 29 Aug 2024; Accepted: 31 Dec 2024.

    Copyright: © 2024 Zhang, Xiaobo and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Bin Zhang, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Sun Xiaobo, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Guibo Sun, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.